BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation

被引：0
|
作者：
Purgina, B. M. [1 ]
Jelic, T. [1 ]
Chiosea, S. I. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
535
引用
收藏
页码：131A / 131A
页数：1
相关论文
共 50 条
  • [1] BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation
    Purgina, B. M.
    Jelic, T.
    Chiosea, S. I.
    LABORATORY INVESTIGATION, 2012, 92 : 131A - 131A
  • [2] Management of V600E and V600K BRAF-Mutant Melanoma
    Haugh, Alexandra M.
    Johnson, Douglas B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [3] Management of V600E and V600K BRAF-Mutant Melanoma
    Alexandra M. Haugh
    Douglas B. Johnson
    Current Treatment Options in Oncology, 2019, 20
  • [4] Clinicopathologic Features of V600E and V600K Melanoma-Letter
    Jewell, Rosalyn
    Chambers, Philip
    Harland, Mark
    Laye, Jon
    Conway, Caroline
    Mitra, Angana
    Elliott, Faye
    Cook, Martin G.
    Boon, Andy
    Newton-Bishop, Julia
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6792 - 6792
  • [5] Clinicopathologic Features of V600E and V600K Melanoma-Response
    Menzies, Alexander M.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6793 - 6793
  • [6] Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
    Menzies, Alexander M.
    Haydu, Lauren E.
    Visintin, Lydia
    Carlino, Matteo S.
    Howle, Julie R.
    Thompson, John F.
    Kefford, Richard F.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3242 - 3249
  • [7] The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma
    Amaral, Teresa
    Nouri, Noura
    Garbe, Claus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 705 - 715
  • [8] Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma
    Li, Yuanyuan
    Umbach, David M.
    Li, Leping
    MELANOMA RESEARCH, 2017, 27 (06) : 527 - 535
  • [9] Clinicopathologic characteristics of BRAF V600K mutant malignant melanoma in comparison with V600E mutant cases: a preliminary study
    Bulbul, G.
    Agalar, A. A.
    Yumuk, E.
    Cagaptay, S.
    Ellidokuz, H.
    Lebe, B.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S130 - S130
  • [10] Characteristics of BRAF V600K versus V600E: Effect of molecular weight change in melanoma
    Joob, Beuy
    Wiwanitkit, Viroj
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (01) : 291 - 291
12345